相关实验视频

Updated: Aug 1, 2026

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein

Published on: January 2, 2015

研究的新途径

Claire E Sexton¹, Gal Bitan², Kathryn R Bowles³

¹Alzheimer's Association, Chicago, Illinois, USA.

Alzheimer's & dementia : the journal of the Alzheimer's Association

|January 3, 2024

概括

国际专家在Tau 2022会议上分享了tau研究的最新创新. 这次活动促进了合作,并突出了推进阿尔茨海默氏症等疾病的tau研究的新工具.

科学领域:

神经科学是一个神经科学.
生物医学研究生物医学研究

背景情况:

陶氏研究最近已经看到加速的创新.
蛋白是神经退行性疾病的关键因素.

研究的目的:

召集国际TAU研究专家.
分享研究的最新进展和新方向.
促进跨部门的合作.

主要方法:

第二届国际陶氏会议"陶氏2022"于2022年2月在虚拟形式举行.
由阿尔茨海默病协会,CurePSP和雨水慈善基金会共同组织和赞助.
来自学术界,工业界和慈善事业的演讲者分享了他们的工作.

主要成果:

来自59个国家的1700多名与会者参加了会议.
介绍了最近的进展和新的研究方向.
讨论了促进研究的新工具和计划.

结论:

会议成功促进了知识交流和合作.
该活动强调了tau研究的快速进展和未来潜力.
会议强调了跨学科努力在促进tau相关疾病的理解和治疗方面的重要性.

关键词:

生物标志物生物标志物知道了,就知道了.tau-PET是一种PET.陶氏病变是一种病变.治疗药物治疗药物

更多相关视频

Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia

Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia

Published on: November 9, 2018

An In Vitro Model for Studying Tau Aggregation Using Lentiviral-mediated Transduction of Human Neurons

An In Vitro Model for Studying Tau Aggregation Using Lentiviral-mediated Transduction of Human Neurons

Published on: May 23, 2019

相关概念视频

Alzheimer Disease ll: Pathophysiology

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...